Kathy Li
Investor Relations Contact chez Dragon Pharmaceutical, Inc.
Profil
Kathy Li is currently the Head of Investor Relations at Dragon Pharmaceutical, Inc. She previously worked as the Director of Investor Relations at Harbin Electric, Inc.
Postes actifs de Kathy Li
| Sociétés | Poste | Début |
|---|---|---|
Dragon Pharmaceutical, Inc.
 Dragon Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Dragon Pharmaceutical, Inc. produces and sells human protein therapeutics. Its products include clenbuterol, oxymetholone, dianabol and deca 300. The company was founded on August 22, 1989 and is headquartered in Vancouver, Canada. | Investor Relations Contact | - |
Anciens postes connus de Kathy Li
| Sociétés | Poste | Fin |
|---|---|---|
Harbin Electric, Inc.
 Harbin Electric, Inc. Electrical ProductsProducer Manufacturing Harbin Electric, Inc. designs, develops, and manufactures linear motors and special electric motors. The company was founded on April 10, 2003 and is headquartered in Harbin, China. | Public Communications Contact | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Dragon Pharmaceutical, Inc.
Dragon Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Dragon Pharmaceutical, Inc. produces and sells human protein therapeutics. Its products include clenbuterol, oxymetholone, dianabol and deca 300. The company was founded on August 22, 1989 and is headquartered in Vancouver, Canada. | Health Technology |
Harbin Electric, Inc.
Harbin Electric, Inc. Electrical ProductsProducer Manufacturing Harbin Electric, Inc. designs, develops, and manufactures linear motors and special electric motors. The company was founded on April 10, 2003 and is headquartered in Harbin, China. | Producer Manufacturing |
